In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters.
From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.
On October 11-13, 2023, ISB will host a virtual course and symposium on how the ecology of our guts protects us from pathogens. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.
ISB researchers Nitin Baliga, Serdar Turkarslan, Mario Arrieta-Ortiz and Yaqiao Li collaborated with the University of Washington to present the first glimpse of the molecular mechanisms behind the unusual lifestyle of a group of tiny microbes called Patescibacteria. The breakthrough was made possible by the discovery of a way to genetically manipulate these bacteria, an advance that has opened a world of possible new research directions.
High school students Ashwin Mukherjee and Rohan Chanani worked with ISB Research Scientist Dr. Jacob Valenzuela on a project to build a machine learning algorithm to count algal cells from microscope images taken from a cell phone. In April, the team was recognized as champions in the DOE-sponsored AlgaePrize competition.
By using a computer model to understand the adaptions of Mycobacterium tuberculosis (Mtb), the pathogen that causes tuberculosis, researchers at ISB have identified a network within Mtb that allows it to tolerate and resist drug therapies. This work is published in Cell Reports.
Pregnant people who are vaccinated are less likely to contract COVID-19 than unvaccinated pregnant people, and those vaccinated and boosted are less likely to get COVID than those who are vaccinated only, according to the first-ever large study of boosters and pregnancy.
ISB kicked off the seventh year of our successful Innovator Award Program by announcing three collaborative projects. This internal program is designed to support novel research ideas that cut across disciplines and research groups.
Popular Mechanics interviewed ISB Co-founder and Professor Dr. Lee Hood for an article titled “Leroy Hood Wants To Show You How To Live for a Really, Really Long Time.” The story features Hood’s big-data approach and a focus on disease prevention – all in the quest to help us live longer.
In their new book, “The Age of Scientific Wellness: Why the Future of Medicine is Personalized, Predictive, Data-Rich, and In Your Hands,” Drs. Lee Hood and Nathan Price introduce a new way of thinking about healthcare – a focus on preventing diseases and optimizing overall wellness.
There is tremendous market and media frenzy around new Alzheimer’s disease drugs, but their efficacy is contested while the potential of prevention is untapped and underreported, Drs. Lee Hood and Nathan Price wrote in an opinion piece published by the Los Angeles Times.
Drs. Lee Hood and Nathan Price, authors of “The Age of Scientific Wellness,” were interviewed by actor and podcaster Dax Sheperd about their new book, and they discussed how AI is changing the medical industry, how infectious disease has impacted our world, the effectiveness of prescriptions, and much more.
Dr. Jennifer Hadlock – an expert in machine learning, immune-mediated inflammatory disease, and maternal/fetal health – has been promoted to associate professor. The Hadlock Lab is an interdisciplinary team that aims to accelerate translational research by integrating clinical data into systems biology at scale.
This essay published by The Wall Street Journal is adapted from “The Age of Scientific Wellness,” the new book by Dr. Lee Hood, co-founder and professor of the Institute for Systems Biology, and Dr. Nathan Price, chief science officer of Thorne HealthTech.
In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.
Bacteria are much more than single-celled organisms swimming around. Bacteria also form communities called biofilm, and work together to maintain the microbial community. Biofilm is just one research area of ISB’s Kuchina Lab. In this Research Roundtable presentation, ISB Assistant Professor Dr. Anna Kuchina details her work studying biofilms.
